The consumer products division of Piramal Enterprises Ltd has acquired trademark rights for five over-the-counter (OTC) drugs for India from Organon India Pvt. Ltd and MSD BV, Indian subsidiaries of US-based pharmaceutical leader Merck and Co., for a consideration of Rs.92 crore, the company said on Wednesday.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
